IDEXX Laboratories, Inc. (IDXX) Q1 2020 Earnings Results

IDEXX Labs Beats on EPS, Stock Up 1.78%

IDEXX Labs reported a positive surprise in earnings per share, which contributed to a 1.78% increase in stock price. This indicates that the company is managing to maintain profitability even amidst broader market uncertainties. Investors may view this as a sign of strength in their veterinary diagnostics segment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.29	N/A	+5.31%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their core business and the resilience of their customer base. They acknowledged the challenges posed by the current environment but remained focused on long-term growth.

Management highlighted strong demand for veterinary diagnostics despite current market challenges.

They emphasized their commitment to innovation and customer support during uncertain times.

IDEXX Labs Beats on EPS, Stock Up 1.78%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Labs Beats on EPS, Stock Up 1.78%

Key numbers

Management commentary